GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » IDenta Corp (OTCPK:IDTA) » Definitions » YoY EBITDA Growth

IDenta (IDenta) YoY EBITDA Growth : -400.00% (As of Jun. 2023)


View and export this data going back to . Start your Free Trial

What is IDenta YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. IDenta's YoY EBITDA Growth for the quarter that ended in Jun. 2023 was -400.00%.

IDenta's EBITDA per Share for the three months ended in Jun. 2023 was $-0.02.


IDenta YoY EBITDA Growth Historical Data

The historical data trend for IDenta's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IDenta YoY EBITDA Growth Chart

IDenta Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
YoY EBITDA Growth
Get a 7-Day Free Trial -47.37 365.00 -63.44 23.53 -64.29

IDenta Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Dec23
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 1,366.67 50.00 -400.00 -100.00

IDenta YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

IDenta's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

YoY EBITDA Growth (A: Dec. 2023 )
=(EBITDA per Share (A: Dec. 2023 )-EBITDA per Share (A: Dec. 2022 ))/ | EBITDA per Share (A: Dec. 2022 ) |
=(0.015-0.042)/ | 0.042 |
=-64.29 %

IDenta's YoY EBITDA Growth for the quarter that ended in Jun. 2023 is calculated as:

YoY EBITDA Growth (Q: Jun. 2023 )
=(EBITDA per Share (Q: Jun. 2023 )-EBITDA per Share (Q: Jun. 2022 )) / | EBITDA per Share (Q: Jun. 2022 )) |
=(-0.015-0.005)/ | 0.005 |
=-400.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


IDenta YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of IDenta's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


IDenta (IDenta) Business Description

Traded in Other Exchanges
N/A
Address
11511 Lamberton Ct, Silver Spring, MD, USA, 20902
IDenta Corp is a detection and forensic science company. The firm, through its subsidiary, is engaged in the business of developing products to test for the presence of illegal drugs and explosives for law enforcement agencies, the military, government agencies, and other organizations. Its product portfolio includes Drug testing kits, Explosive testing kits, Precursors of Drugs Test kits, portable sniffers, Bullet-hole testing kits, and others. The Company currently sells its products to law enforcement organizations in the following countries Indonesia, Argentina, Poland, France, USA, Spain, India, the United Kingdom, Ghana, Nigeria, Australia, Russia, Israel, Canada, Germany, Italy, and Portugal. The Company also sells to retail markets in the United States, Italy, and South Africa.